Cardax, Inc.
CDXI · OTC
3/31/2021 | 12/31/2020 | 9/30/2020 | 6/30/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -46.4% | 193.4% | -50.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 63.3% | 65.8% | 58.6% | 71.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -737.6% | -339.2% | -1,061.3% | -586.5% |
| Other Income/Exp. Net | -$1 | -$0 | -$1 | -$1 |
| Pre-Tax Income | -$1 | -$1 | -$1 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$1 | -$2 | -$3 |
| % Margin | -1,740.8% | -704.6% | -2,668.1% | -2,016.4% |
| EPS | -2.29 | -1.79 | -2.35 | -3.6 |
| % Growth | -27.9% | 23.8% | 34.7% | – |
| EPS Diluted | -2.29 | -1.79 | -2.35 | -3.6 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $0 | $1 |
| Depreciation & Amortization | $0 | -$0 | $0 | $0 |
| EBITDA | -$1 | -$0 | -$1 | -$1 |
| % Margin | -894.6% | -243.5% | -1,391.8% | -512.5% |